2 Followers USX:A - Agilent Technologies Inc Agilent Technologies Inc
Sector: Health Care, Industry: Life Sciences Tools & Services
Add to Watchlist
   
Add Alert 


Yahoo Finance
Quarterly TTM
Balance Sheet Cash Flow Key Ratios Personalized

Graphs are exclusive for members only

Sign up for free to access most features of StocksCafe

Show %
1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Graph
Total Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 4.91B
9.9%
5.16B
5.1%
5.34B
3.4%
Cost of Revenue [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 2.23B
7.8%
2.36B
5.6%
2.5B
6.1%
Gross Profit [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 2.68B
11.7%
2.81B
4.7%
2.84B
1.1%
Total Expenses [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 4.01B
9.4%
4.22B
5.3%
4.49B
6.4%
Operating Expense [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 1.78B
11.6%
1.86B
5.0%
1.99B
6.8%
Operating Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 904M
12.0%
941M
4.1%
846M
-10.1%
Net Income (Cont Operations) [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 316M
-53.8%
1.07B
238.9%
719M
-32.9%
Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 316M
-53.8%
1.07B
238.9%
719M
-32.9%
Diluted Net Income [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 316M
-53.8%
1.07B
238.9%
719M
-32.9%
Basic EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.98
-53.8%
3.41
248.0%
2.33
-31.7%
Diluted EPS [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] [friend] 0.97
-53.8%
3.37
247.4%
2.3
-31.8%
Values are in USD whenever applicable | Fiscal year ends on October 31
Powered by Morningstar